How To Seize The Opportunity For Pharmaceutical Equipment Enterprises
Jun 29, 2022
Pharmaceutical equipment is the upstream of the pharmaceutical industry, and its technical level determines the strength of the pharmaceutical level. In recent years, driven by the high boom of the downstream pharmaceutical industry and the support of favorable policies, my country's pharmaceutical equipment has accelerated the upgrade, and the industry market scale is on the rise. In 2020, it has reached 35 billion yuan. The industry is expected to continue to grow in the future. By 2021 The year is approaching 40 billion yuan, and will increase to about 44 billion yuan by 2022. From the data, it can be seen that my country's pharmaceutical equipment market has a promising future. So, as the new year is approaching, how should pharmaceutical equipment companies seize the opportunity?
"The development situation of the pharmaceutical equipment industry is undoubtedly good, but opportunities often coexist with challenges. Enterprises should start from the bottleneck and solve them one by one." Some insiders pointed out that at present, the talents, R&D level, service quality and other aspects are all domestic pharmaceutical equipment. The shortcomings of the enterprise, only by strengthening the research, can the domestic pharmaceutical machinery enterprises reach a new level.
Regarding the shortcomings of talents in pharmaceutical machinery companies, the industry suggests that, on the one hand, companies need to pay more attention to talents and attract and retain talents in terms of remuneration, promotion space, and benefits. In recent years, our Guangdong RICH PACKING has paid more and more attention to talent training, recruiting talents through various methods such as cooperation with schools and enterprises, improving salary and benefits; on the other hand, it is also necessary for the industry to build a sound talent policy system and introduce relevant support drugs. The policies and documents for the development of talents allow talents to concentrate on doing "big things" and help the development of pharmaceutical machinery companies and the industry.